核苷与核苷酸|Nucleosides & Nucleotides-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

核苷是糖胺，可以被认为是不含磷酸基的核苷酸。核苷由一个核苷酸(也称为氮基)和一个五碳糖(核糖或脱氧核糖)组成，而核苷酸由一个核苷酸、一个五碳糖和一个或多个磷酸基组成。在核苷中，碱基通过-糖苷键与核糖或脱氧核糖结合。核苷酸是有机分子，是构成核酸聚合物的单体单位，脱氧核糖核酸(DNA)和核糖核酸(RNA)，两者都是地球上所有生命形式中必不可少的生物分子。核苷酸是核酸的基本组成部分;它们由三个亚基分子组成:一个氮基、一个五碳糖(核糖或脱氧核糖)和至少一个磷酸基。核苷是含氮的碱和5碳的糖。因此，一个核苷加上一个磷酸基产生一个核苷酸。

1-((2R,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 1-((2R,3R,4R,5R)-3,4-二羟基-5-(羟甲基)-3-甲基四氢呋喃-2-基)嘧啶-2,4(1H,3H)-二酮: BJS848310031448-54-197%; ￥172.001g

1-((2R,4S,5S)-4-Azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione 1-((2R,4S,5S)-4-叠氮基-5-(羟甲基)四氢呋喃-2-基)-5-甲基嘧啶-2,4(1H,3H)-二酮: BJS074112730516-87-199%; ￥365.005g

Sodium ((2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate ((2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1(2H)-基)-3-羟基四氢呋喃-2-基)甲基磷酸二钠盐: BJS082409313085-50-298%; ￥124.00100mg

(2R,3S,4R,5R)-2-(6-Amino-9H-purin-9-yl)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol (2R,3S,4R,5R)-2-(6-氨基-9H-嘌呤-9-基)-4-氟-5-(羟甲基)四氢呋喃-3-醇: BJS643300020535-16-497%; ￥4673.0025mg

(2R,3R,4S,5R)-2-(2-Chloro-6-methoxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (2R,3R,4S,5R)-2-(2-氯-6-甲氧基-9H-嘌呤-9-基)-5-(羟甲基)四氢呋喃-3,4-二醇: BJS086261415465-92-696%; ￥395.00250mg

1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidine-2,4(1H,3H)-dione 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-甲氧基嘧啶-2,4(1H,3H)-二酮: BJS352039535542-01-995%; ￥172.00250mg

4-Amino-5-ethynyl-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-氨基-5-乙炔基-1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮: BJS198106469075-47-498%; ￥1094.00250mg

(2R,3R,4S,5R)-2-(6-Amino-8-bromo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (2R,3R,4S,5R)-2-(6-氨基-8-溴-9H-嘌呤-9-基)-5-(羟甲基)四氢呋喃-3,4-二醇: BJS95843202946-39-698%; ￥168.005g

4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-氨基-5-溴-1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮: BJS83212103066-86-295%; ￥825.005g

(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate 2',3',5'-三乙酰腺苷: BJS94388777387-57-798%; ￥995.00100g

5-Ethynyl-2'-dU 5-乙炔基-1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2,4(1H,3H)-二酮: BJS619335261135-33-998%; ￥6260.005g

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione 1-((2R,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)-5-甲基嘧啶-2,4(1H,3H)-二酮: BJS497565050-89-598%; ￥65.0025g

1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-5-氟嘧啶-2,4(1H,3H)-二酮: BJS6814033316-46-197%; ￥暂无

Sodium ((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl phosphate ((2R,3S,5R)-5-(6-氨基-9H-嘌呤-9-基)-3-羟基四氢呋喃-2-基)甲基磷酸钠: BJS77206232922-74-995%; ￥8726.005g

N4-Methylcytidine 1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-4-(甲氨基)嘧啶-2(1H)-酮: BJS687198610578-79-798%; ￥5082.001g

((2R,3S,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate ((2R,3S,5R)-5-(4-氨基-2-氧代嘧啶-1(2H)-基)-3-羟基四氢呋喃-2-基)甲基磷酸二氢酯: BJS26992711032-65-195%; ￥525.00250mg

(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol (2R,3R,4S,5R)-2-(6-氨基-9H-嘌呤-9-基)-5-(羟甲基)四氢呋喃-3,4-二醇: BJS113888558-61-798%; ￥97.00100g

4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-氨基-1-((2R,3S,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮: BJS0527858147-94-498%; ￥414.0025g

2-Amino-9-((2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one 2-氨基-9-((2R,3R,5S)-3-羟基-5-(羟甲基)四氢呋喃-2-基)-1H-嘌呤-6(9H)-酮: BJS20991023608-58-095%; ￥1329.00250mg

9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-2-(methylamino)-1,9-dihydro-6H-purin-6-one 9-((2R,3R,4R,5R)-4-羟基-5-(羟甲基)-3-甲氧基四氢呋喃-2-基)-2-(甲氨基)-1,9-二氢-6H-嘌呤-6-酮: BJS6118045135023-21-198%; ￥1848.00100mg

1 2 3 4 5 6 7 8 9 ... 20